{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:30:45Z","timestamp":1793223045664,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:00:00Z","timestamp":1658188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:00:00Z","timestamp":1658188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Patients with obstructive sleep apnea\/hypopnea (OSA) are at high risk of cerebrovascular diseases leading to cognitive impairment. The oxidative stress generated by intermittent hypoxia (IH) could lead to an increase in blood\u2013brain barrier (BBB) permeability, an essential interface for the protection of the brain. Moreover, in patients with OSA, blood coagulation could be increased leading to cardiovascular complications. Thrombin is a factor found increased in these populations that exerts various cellular effects through activation of protease activated receptors (PARs). Thus, we have evaluated in an in vitro BBB model the association of IH with thrombin at two concentrations. We measured the apparent BBB permeability, expression of tight junctions, ROS production, HIF-1\u03b1 expression, and cleavage of PAR-1\/PAR-3. Pre-treatment with dabigatran was performed. IH and higher thrombin concentrations altered BBB permeability: high levels of HIF-1\u03b1 expression, ROS and PAR-1 activation compared to PAR-3 in such conditions. Conversely, lower concentration of thrombin associated with IH appear to have a protective effect on BBB with a significant cleavage of PAR-3. Dabigatran reversed the deleterious effect of thrombin at high concentrations but also suppressed the beneficial effect of low dose thrombin. Therefore, thrombin and PARs represent novel attractive targets to prevent BBB opening in OSA.<\/jats:p>","DOI":"10.1038\/s41598-022-15592-x","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T11:06:28Z","timestamp":1658228788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Effects of intermittent hypoxia with thrombin in an in vitro model of human brain endothelial cells and their impact on PAR-1\/PAR-3 cleavage"],"prefix":"10.1038","volume":"12","author":[{"given":"Cindy","family":"Zolotoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mentine","family":"Puech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Perek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,19]]},"reference":[{"key":"15592_CR1","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1146\/annurev.me.27.020176.002341","volume":"27","author":"C Guilleminault","year":"1976","unstructured":"Guilleminault, C., Tilkian, A. & Dement, W. C. The sleep apnea syndromes. Annu. Rev. Med. 27, 465\u2013484 (1976).","journal-title":"Annu. Rev. Med."},{"key":"15592_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.smrv.2014.07.003","volume":"20","author":"L Lavie","year":"2015","unstructured":"Lavie, L. Oxidative stress in obstructive sleep apnea and intermittent hypoxia \u2013 Revisited \u2013 The bad ugly and good: Implications to the heart and brain. Sleep Med. Rev. 20, 27\u201345 (2015).","journal-title":"Sleep Med. Rev."},{"key":"15592_CR3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.resp.2010.09.001","volume":"174","author":"Y Wang","year":"2010","unstructured":"Wang, Y., Zhang, S. X. L. & Gozal, D. Reactive oxygen species and the brain in sleep apnea. Respir. Physiol. Neurobiol. 174, 307\u2013316 (2010).","journal-title":"Respir. Physiol. Neurobiol."},{"key":"15592_CR4","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.jacc.2008.12.050","volume":"53","author":"E Belaidi","year":"2009","unstructured":"Belaidi, E. et al. Major role for hypoxia inducible factor-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea. J. Am. Coll. Cardiol. 53, 1309\u20131317 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"15592_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1146\/annurev-physiol-021113-170322","volume":"76","author":"GL Semenza","year":"2014","unstructured":"Semenza, G. L. Hypoxia-Inducible Factor 1 and Cardiovascular Disease. Annu. Rev. Physiol. 76, 39\u201356 (2014).","journal-title":"Annu. Rev. Physiol."},{"key":"15592_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.smrv.2012.12.003","volume":"18","author":"DC Lim","year":"2014","unstructured":"Lim, D. C. & Pack, A. I. Obstructive sleep apnea and cognitive impairment: Addressing the blood\u2013brain barrier. Sleep Med. Rev. 18, 35\u201348 (2014).","journal-title":"Sleep Med. Rev."},{"issue":"1","key":"15592_CR7","doi-asserted-by":"publisher","first-page":"a020412","DOI":"10.1101\/cshperspect.a020412","volume":"7","author":"R Daneman","year":"2015","unstructured":"Daneman, R. & Prat, A. The Blood-Brain Barrier. Cold Spring Harb. Perspect. Biol. 7(1), a020412 (2015).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"15592_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.addr.2019.11.009","volume":"165\u2013166","author":"R Pandit","year":"2020","unstructured":"Pandit, R., Chen, L. & G\u00f6tz, J. The blood-brain barrier: Physiology and strategies for drug delivery. Adv. Drug Deliv. Rev. 165\u2013166, 1\u201314 (2020).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"15592_CR9","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1083\/jcb.201412147","volume":"209","author":"S Tietz","year":"2015","unstructured":"Tietz, S. & Engelhardt, B. Brain barriers: Crosstalk between complex tight junctions and adherens junctions. J. Cell. Biol. 209, 493\u2013506 (2015).","journal-title":"J. Cell. Biol."},{"key":"15592_CR10","doi-asserted-by":"publisher","first-page":"a002899","DOI":"10.1101\/cshperspect.a002899","volume":"1","author":"W Meng","year":"2009","unstructured":"Meng, W. & Takeichi, M. Adherens junction: molecular architecture and regulation. Cold Spring Harb. Perspect. Biol. 1, a002899 (2009).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"15592_CR11","doi-asserted-by":"crossref","unstructured":"Eisele, H.-J., Markart, P. & Schulz, R. Obstructive sleep apnea, oxidative stress, and cardiovascular disease: evidence from human studies. Oxid. Med. Cell Longev. 2015, (2015).","DOI":"10.1155\/2015\/608438"},{"key":"15592_CR12","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/jcb.25074","volume":"116","author":"S Movafagh","year":"2015","unstructured":"Movafagh, S., Crook, S. & Vo, K. Regulation of hypoxia-inducible factor-1a by reactive oxygen species: new developments in an old debate. J Cell Biochem. 116, 696\u2013703 (2015).","journal-title":"J Cell Biochem."},{"key":"15592_CR13","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.5664\/jcsm.8682","volume":"16","author":"A Gabryelska","year":"2020","unstructured":"Gabryelska, A. et al. Patients with obstructive sleep apnea present with chronic upregulation of serum HIF-1\u03b1 protein. J. Clin. Sleep Med. 16, 1761\u20131768 (2020).","journal-title":"J. Clin. Sleep Med."},{"key":"15592_CR14","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1001\/jamaoto.2017.1367","volume":"143","author":"S-N Hong","year":"2017","unstructured":"Hong, S.-N., Yun, H.-C., Yoo, J. H. & Lee, S. H. Association between hypercoagulability and severe obstructive sleep apnea. JAMA Otolaryngol. Head Neck Surg. 143, 996\u20131002 (2017).","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"15592_CR15","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1155\/2011\/924629","volume":"18","author":"C Liak","year":"2011","unstructured":"Liak, C. & Fitzpatrick, M. Coagulability in obstructive sleep apnea. Can. Respir. J. 18, 338\u2013348 (2011).","journal-title":"Can. Respir. J."},{"key":"15592_CR16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3233\/CH-2009-1175","volume":"41","author":"M Tazbirek","year":"2009","unstructured":"Tazbirek, M., Slowinska, L., Skoczynski, S. & Pierzchala, W. Short-term continuous positive airway pressure therapy reverses the pathological influence of obstructive sleep apnea on blood rheology parameters. Clin. Hemorheol. Microcirc. 41, 241\u2013249 (2009).","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"15592_CR17","first-page":"1426","volume":"116","author":"X Zhang","year":"2003","unstructured":"Zhang, X., Yin, K., Wang, H., Su, M. & Yang, Y. Effect of continuous positive airway pressure treatment on elderly Chinese patients with obstructive sleep apnea in the prethrombotic state. Chin. Med. J. 116, 1426\u20131428 (2003).","journal-title":"Chin. Med. J."},{"key":"15592_CR18","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000063625","volume":"69","author":"T Geiser","year":"2002","unstructured":"Geiser, T. et al. In vivo platelet activation is increased during sleep in patients with obstructive sleep apnea syndrome. Respiration 69, 229\u2013234 (2002).","journal-title":"Respiration"},{"key":"15592_CR19","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201911-2229OC","author":"A Kontos","year":"2020","unstructured":"Kontos, A. et al. Increased platelet aggregation in children and adolescents with sleep disordered breathing. Am. J. Respir. Crit. Care Med. https:\/\/doi.org\/10.1164\/rccm.201911-2229OC (2020).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"15592_CR20","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/thx.2003.018739","volume":"59","author":"GV Robinson","year":"2004","unstructured":"Robinson, G. V., Pepperell, J. C. T., Segal, H. C., Davies, R. J. O. & Stradling, J. R. Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax 59, 777\u2013782 (2004).","journal-title":"Thorax"},{"key":"15592_CR21","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/35025229","volume":"407","author":"SR Coughlin","year":"2000","unstructured":"Coughlin, S. R. Thrombin signalling and protease-activated receptors. Nature 407, 258\u2013264 (2000).","journal-title":"Nature"},{"key":"15592_CR22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1182\/blood-2015-11-636472","volume":"128","author":"MT Nieman","year":"2016","unstructured":"Nieman, M. T. Protease-activated receptors in hemostasis. Blood 128, 169\u2013177 (2016).","journal-title":"Blood"},{"key":"15592_CR23","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1182\/blood-2013-03-488957","volume":"122","author":"L Burnier","year":"2013","unstructured":"Burnier, L. & Mosnier, L. O. Novel mechanisms for activated protein C cytoprotective activities involving noncanonical activation of protease-activated receptor 3. Blood 122, 807\u2013816 (2013).","journal-title":"Blood"},{"key":"15592_CR24","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1160\/TH08-03-0131","volume":"100","author":"E Sokolova","year":"2008","unstructured":"Sokolova, E. & Reiser, G. Prothrombin\/thrombin and the thrombin receptors PAR-1 and PAR-4 in the brain: localization, expression and participation in neurodegenerative diseases. Thromb. Haemost. 100, 576\u2013581 (2008).","journal-title":"Thromb. Haemost."},{"key":"15592_CR25","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1073\/pnas.040552897","volume":"97","author":"F Striggow","year":"2000","unstructured":"Striggow, F. et al. The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. Proc. Natl. Acad. Sci. U S A 97, 2264\u20132269 (2000).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"15592_CR26","doi-asserted-by":"publisher","first-page":"5389","DOI":"10.1523\/JNEUROSCI.15-07-05389.1995","volume":"15","author":"P Vaughan","year":"1995","unstructured":"Vaughan, P., Pike, C., Cotman, C. & Cunningham, D. Thrombin receptor activation protects neurons and astrocytes from cell death produced by environmental insults. J. Neurosci. 15, 5389\u20135401 (1995).","journal-title":"J. Neurosci."},{"key":"15592_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1046\/j.1471-4159.2003.01268.x","volume":"84","author":"G Xi","year":"2003","unstructured":"Xi, G., Reiser, G. & Keep, R. F. The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: deleterious or protective?. J. Neurochem. 84, 3\u20139 (2003).","journal-title":"J. Neurochem."},{"key":"15592_CR28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3233\/JAD-200658","volume":"79","author":"HV Rao","year":"2021","unstructured":"Rao, H. V., Bihaqi, S. W., Iannucci, J., Sen, A. & Grammas, P. Thrombin signaling contributes to high glucose-induced injury of human brain microvascular endothelial cells. J. Alzheimers Dis. 79, 211\u2013224 (2021).","journal-title":"J. Alzheimers Dis."},{"key":"15592_CR29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.brainres.2016.12.011","volume":"1657","author":"E Brailoiu","year":"2017","unstructured":"Brailoiu, E., Shipsky, M. M., Yan, G., Abood, M. E. & Brailoiu, G. C. Mechanisms of modulation of brain microvascular endothelial cells function by thrombin. Brain Res. 1657, 167\u2013175 (2017).","journal-title":"Brain Res."},{"key":"15592_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-016-0670-z","volume":"13","author":"BW Festoff","year":"2016","unstructured":"Festoff, B. W., Sajja, R. K., van Dreden, P. & Cucullo, L. HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer\u2019s disease. J. Neuroinflamm. 13, 1\u201312 (2016).","journal-title":"J. Neuroinflamm."},{"key":"15592_CR31","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/jcp.21718","volume":"219","author":"J-S Bae","year":"2009","unstructured":"Bae, J.-S., Kim, Y., Park, M.-K. & Rezaie, A. R. Concentration dependent dual effect of thrombin in endothelial cells via PAR-1 and PI3 kinase. J. Cell Physiol. 219, 744\u2013751 (2009).","journal-title":"J. Cell Physiol."},{"key":"15592_CR32","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.33594\/000000311","volume":"54","author":"C Zolotoff","year":"2020","unstructured":"Zolotoff, C., Voirin, A.-C., Puech, C., Roche, F. & Perek, N. Intermittent hypoxia and its impact on Nrf2\/HIF-1\u03b1 expression and ABC transporters: an in vitro human blood-brain barrier model study. Cell Physiol. Biochem. 54, 1231\u20131248 (2020).","journal-title":"Cell Physiol. Biochem."},{"key":"15592_CR33","doi-asserted-by":"publisher","first-page":"C745","DOI":"10.1152\/ajpcell.00313.2013","volume":"306","author":"VV Makarenko","year":"2014","unstructured":"Makarenko, V. V. et al. Intermittent hypoxia-induced endothelial barrier dysfunction requires ROS-dependent MAP kinase activation. Am. J. Physiol. Cell Physiol. 306, C745\u2013C752 (2014).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"15592_CR34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.brainres.2019.05.024","volume":"1719","author":"C Puech","year":"2019","unstructured":"Puech, C. et al. Direct oral anticoagulants are associated with limited damage of endothelial cells of the blood-brain barrier mediated by the thrombin\/PAR-1 pathway. Brain Res. 1719, 57\u201363 (2019).","journal-title":"Brain Res."},{"key":"15592_CR35","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1161\/hh1301.092678","volume":"89","author":"A G\u00f6rlach","year":"2001","unstructured":"G\u00f6rlach, A. et al. Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: Role of the p22(phox)-containing NADPH oxidase. Circ. Res. 89, 47\u201354 (2001).","journal-title":"Circ. Res."},{"key":"15592_CR36","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/jcbfm.2015.9","volume":"35","author":"BT Hawkins","year":"2015","unstructured":"Hawkins, B. T., Gu, Y.-H., Izawa, Y. & del Zoppo, G. J. Dabigatran abrogates brain endothelial cell permeability in response to thrombin. J. Cereb. Blood Flow Metab. 35, 985\u2013992 (2015).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"15592_CR37","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/rr79","volume":"2","author":"P Lanfranchi","year":"2001","unstructured":"Lanfranchi, P. & Somers, V. A. Obstructive sleep apnea and vascular disease. Respir Res 2, 315\u2013319 (2001).","journal-title":"Respir Res"},{"key":"15592_CR38","first-page":"369","volume":"33","author":"R von K\u00e4nel","year":"2005","unstructured":"von K\u00e4nel, R., Loredo, J. S., Powell, F. L., Adler, K. A. & Dimsdale, J. E. Short-term isocapnic hypoxia and coagulation activation in patients with sleep apnea. Clin. Hemorheol. Microcirc. 33, 369\u2013377 (2005).","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"15592_CR39","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/ijms17010084","volume":"17","author":"H Krenzlin","year":"2016","unstructured":"Krenzlin, H., Lorenz, V., Danckwardt, S., Kempski, O. & Alessandri, B. The importance of thrombin in cerebral injury and disease. Int. J. Mol. Sci. 17, 84 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"15592_CR40","unstructured":"Gawdi, R. & Emmady, P. D. Physiology, Blood Brain Barrier. in StatPearls (StatPearls Publishing, 2020)."},{"key":"15592_CR41","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.redox.2015.10.009","volume":"6","author":"N Carrim","year":"2015","unstructured":"Carrim, N. et al. Thrombin-induced reactive oxygen species generation in platelets: a novel role for protease-activated receptor 4 and GPIb\u03b1. Redox Biol. 6, 640\u2013647 (2015).","journal-title":"Redox Biol."},{"key":"15592_CR42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.vph.2013.11.001","volume":"60","author":"JK Friedman","year":"2014","unstructured":"Friedman, J. K. et al. Intermittent hypoxia-induced increases in reactive oxygen species activate NFATc3 increasing endothelin-1 vasoconstrictor reactivity. Vascul. Pharmacol. 60, 17\u201324 (2014).","journal-title":"Vascul. Pharmacol."},{"key":"15592_CR43","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1038\/jcbfm.2010.29","volume":"30","author":"JJ Lochhead","year":"2010","unstructured":"Lochhead, J. J. et al. Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation. J. Cereb. Blood Flow Metab. 30, 1625\u20131636 (2010).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"15592_CR44","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1080\/10715760902751902","volume":"43","author":"PBL Pun","year":"2009","unstructured":"Pun, P. B. L., Lu, J. & Moochhala, S. Involvement of ROS in BBB dysfunction. Free Radic. Res. 43, 348\u2013364 (2009).","journal-title":"Free Radic. Res."},{"key":"15592_CR45","doi-asserted-by":"crossref","unstructured":"Song, K. et al. Oxidative Stress-Mediated Blood-Brain Barrier (BBB) Disruption in Neurological Diseases. Oxidative Medicine and Cellular Longevity vol. 2020 e4356386 https:\/\/www.hindawi.com\/journals\/omcl\/2020\/4356386\/ (2020).","DOI":"10.1155\/2020\/4356386"},{"key":"15592_CR46","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/carcin\/bgn032","volume":"29","author":"S-N Jung","year":"2008","unstructured":"Jung, S.-N. et al. Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via AMP-activated protein kinase in DU145 human prostate cancer cells. Carcinogenesis 29, 713\u2013721 (2008).","journal-title":"Carcinogenesis"},{"key":"15592_CR47","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1002\/jcp.24544","volume":"229","author":"S Engelhardt","year":"2014","unstructured":"Engelhardt, S., Al-Ahmad, A. J., Gassmann, M. & Ogunshola, O. O. Hypoxia selectively disrupts brain microvascular endothelial tight junction complexes through a hypoxia-inducible factor-1 (HIF-1) dependent mechanism. J. Cell. Physiol. 229, 1096\u20131105 (2014).","journal-title":"J. Cell. Physiol."},{"key":"15592_CR48","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1124\/mol.107.036418","volume":"72","author":"W-L Yeh","year":"2007","unstructured":"Yeh, W.-L., Lu, D.-Y., Lin, C.-J., Liou, H.-C. & Fu, W.-M. Inhibition of hypoxia-induced increase of blood-brain barrier permeability by YC-1 through the antagonism of HIF-1\u03b1 accumulation and VEGF expression. Mol. Pharmacol. 72, 440\u2013449 (2007).","journal-title":"Mol. Pharmacol."},{"key":"15592_CR49","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/febs.15055","volume":"287","author":"G Pontarollo","year":"2020","unstructured":"Pontarollo, G. et al. Protease-activated receptor signaling in intestinal permeability regulation. FEBS J. 287, 645\u2013658 (2020).","journal-title":"FEBS J."},{"key":"15592_CR50","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/386502a0","volume":"386","author":"H Ishihara","year":"1997","unstructured":"Ishihara, H. et al. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 386, 502\u2013506 (1997).","journal-title":"Nature"},{"key":"15592_CR51","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12959-019-0194-8","volume":"17","author":"DM Heuberger","year":"2019","unstructured":"Heuberger, D. M. & Schuepbach, R. A. Protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases. Thromb. J. 17, 4 (2019).","journal-title":"Thromb. J."},{"key":"15592_CR52","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.molbrainres.2003.12.001","volume":"122","author":"E Pompili","year":"2004","unstructured":"Pompili, E. et al. Trimethyltin-induced differential expression of PAR subtypes in reactive astrocytes of the rat hippocampus. Brain Res. Mol. Brain Res. 122, 93\u201398 (2004).","journal-title":"Brain Res. Mol. Brain Res."},{"key":"15592_CR53","doi-asserted-by":"publisher","first-page":"S156","DOI":"10.1016\/S0049-3848(07)70190-1","volume":"120","author":"I Filippi","year":"2007","unstructured":"Filippi, I., Ardinghi, C., Giavazzi, R., Carraro, F. & Naldini, A. PO-37 Hypoxia induces the expression of protease-activated receptor (PAR)-1 through the hypoxic inducible factor (HIF)-1\u03b1 in MDA-MB-231 breast cancer cells. Thromb. Res. 120, S156 (2007).","journal-title":"Thromb. Res."},{"key":"15592_CR54","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1160\/TH08-02-0127","volume":"100","author":"J-S Bae","year":"2008","unstructured":"Bae, J.-S. & Rezaie, A. R. Protease activated receptor 1 (PAR-1) activation by thrombin is protective in human pulmonary artery endothelial cells if endothelial protein C receptor is occupied by its natural ligand. Thromb. Haemost. 100, 101\u2013109 (2008).","journal-title":"Thromb. Haemost."},{"key":"15592_CR55","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1161\/ATVBAHA.110.203604","volume":"30","author":"WG Eisert","year":"2010","unstructured":"Eisert, W. G. et al. Dabigatran: an oral novel potent reversible nonpeptide inhibitor of thrombin. Arterioscler. Thromb. Vasc. Biol. 30, 1885\u20131889 (2010).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"15592_CR56","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00893-2018","author":"A Garc\u00eda-Ortega","year":"2018","unstructured":"Garc\u00eda-Ortega, A. et al. Obstructive sleep apnoea and venous thromboembolism: pathophysiological links and clinical implications. Eur. Respir. J. https:\/\/doi.org\/10.1183\/13993003.00893-2018 (2018).","journal-title":"Eur. Respir. J."},{"key":"15592_CR57","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fphar.2013.00012","volume":"4","author":"J van Ryn","year":"2013","unstructured":"van Ryn, J. et al. The discovery of dabigatran etexilate. Front Pharmacol 4, 12 (2013).","journal-title":"Front Pharmacol"},{"key":"15592_CR58","doi-asserted-by":"publisher","first-page":"5662","DOI":"10.1073\/pnas.0700763104","volume":"104","author":"JN McLaughlin","year":"2007","unstructured":"McLaughlin, J. N., Patterson, M. M. & Malik, A. B. Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization. PNAS 104, 5662\u20135667 (2007).","journal-title":"PNAS"},{"key":"15592_CR59","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1124\/mol.116.106666","volume":"91","author":"MT Duvernay","year":"2017","unstructured":"Duvernay, M. T. et al. Contributions of Protease-Activated Receptors PAR1 and PAR4 to Thrombin-Induced GPIIbIIIa Activation in Human Platelets. Mol Pharmacol 91, 39\u201347 (2017).","journal-title":"Mol Pharmacol"},{"key":"15592_CR60","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1378\/chest.108.3.625","volume":"108","author":"G Bokinsky","year":"1995","unstructured":"Bokinsky, G., Miller, M., Ault, K., Husband, P. & Mitchell, J. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure A preliminary investigation. Chest 108, 625\u2013630 (1995).","journal-title":"Chest"},{"key":"15592_CR61","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.neuroscience.2018.02.039","volume":"377","author":"E Brailoiu","year":"2018","unstructured":"Brailoiu, E., Barlow, C. L., Ramirez, S. H., Abood, M. E. & Brailoiu, G. C. Effects of platelet-activating factor on brain microvascular endothelial cells. Neuroscience 377, 105\u2013113 (2018).","journal-title":"Neuroscience"},{"key":"15592_CR62","doi-asserted-by":"publisher","first-page":"6015","DOI":"10.1182\/blood-2008-10-186650","volume":"113","author":"J Kisucka","year":"2009","unstructured":"Kisucka, J. et al. Elevated levels of soluble P-selectin in mice alter blood-brain barrier function, exacerbate stroke, and promote atherosclerosis. Blood 113, 6015\u20136022 (2009).","journal-title":"Blood"},{"key":"15592_CR63","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jneuroim.2017.01.024","volume":"305","author":"H Masuda","year":"2017","unstructured":"Masuda, H. et al. Soluble CD40 ligand contributes to blood-brain barrier breakdown and central nervous system inflammation in multiple sclerosis and neuromyelitis optica spectrum disorder. J. Neuroimmunol. 305, 102\u2013107 (2017).","journal-title":"J. Neuroimmunol."},{"key":"15592_CR64","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ijpharm.2018.09.040","volume":"551","author":"C Puech","year":"2018","unstructured":"Puech, C. et al. Assessment of HBEC-5i endothelial cell line cultivated in astrocyte conditioned medium as a human blood-brain barrier model for ABC drug transport studies. Int. J. Pharm. 551, 281\u2013289 (2018).","journal-title":"Int. J. Pharm."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15592-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15592-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15592-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T04:39:31Z","timestamp":1669351171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15592-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,19]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["15592"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-15592-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,19]]},"assertion":[{"value":"14 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12305"}}